$TMGI
Marquie Group, Inc.

2022 Q4 Form 10-Q Financial Statement

#000171254322000170 Filed on October 24, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $183.1K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $780.00 $389.00
YoY Change
% of Gross Profit
Operating Expenses $88.69K $99.43K
YoY Change 17.02%
Operating Profit -$88.69K -$99.43K
YoY Change 17.02% 191.05%
Interest Expense $79.92K $40.24K
YoY Change -51.64% -83.46%
% of Operating Profit
Other Income/Expense, Net -$79.92K $40.24K
YoY Change -105.04% -98.64%
Pretax Income $1.634M -$139.7K
YoY Change -95.35%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$168.6K -$139.7K
YoY Change -111.16% -95.35%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 16.19M shares 16.19M shares
Diluted Shares Outstanding 292.9M shares 16.19M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $780.00
YoY Change
Cash & Equivalents $784.00 $0.00 $353.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.389K $4.309K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $784.00 $0.00 $353.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.390K
YoY Change
Goodwill
YoY Change
Intangibles $10.37K $10.37K $10.37K
YoY Change
Long-Term Investments $6.200M
YoY Change
Other Assets $6.221M $12.53K
YoY Change
Total Long-Term Assets $6.221M $12.14K $12.53K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $784.00 $0.00 $353.00
Total Long-Term Assets $6.221M $12.14K $12.53K
Total Assets $6.222M $12.14K $12.89K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $71.32K $55.83K $35.41K
YoY Change
Accrued Expenses $1.435M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.470M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.809M $5.806M $5.668M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.809M $5.806M $5.668M
Total Long-Term Liabilities $0.00
Total Liabilities $7.809M $5.806M $5.668M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$16.16M -$16.02M -$15.88M
YoY Change
Common Stock $75.66K $1.621K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.587M -$5.794M -$5.655M
YoY Change
Total Liabilities & Shareholders Equity $6.222M $12.14K $12.89K
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$168.6K -$139.7K
YoY Change -111.16% -95.35%
Depreciation, Depletion And Amortization $780.00 $389.00
YoY Change
Cash From Operating Activities -$47.66K -$26.80K
YoY Change 216.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$9.250K
YoY Change
Cash From Investing Activities -$9.250K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 57.34K $26.44K
YoY Change 211.93%
NET CHANGE
Cash From Operating Activities -47.66K -$26.80K
Cash From Investing Activities -9.250K $0.00
Cash From Financing Activities 57.34K $26.44K
Net Change In Cash 430.0 -$353.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$47.66K -$26.80K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
353 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
2167 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
1778 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
12532 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
12143 usd
CY2022Q2 us-gaap Assets
Assets
12885 usd
CY2022Q3 us-gaap Assets
Assets
12143 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
35405 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
55826 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
334180 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
370537 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
981917 usd
CY2022Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1419108 usd
CY2022Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1457988 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
135551 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
123051 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5667562 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5806482 usd
CY2022Q2 us-gaap Liabilities
Liabilities
5667562 usd
CY2022Q3 us-gaap Liabilities
Liabilities
5806482 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10213431 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10213431 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12885 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12143 usd
CY2022Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2022Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1621 usd
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1621 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
8460 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
8460 usd
CY2022Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2022Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2022Q2 TMGI Common Stock Payable
CommonStockPayable
-1 shares
CY2022Q3 TMGI Common Stock Payable
CommonStockPayable
-1 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16189732 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16192332 shares
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 dei Entity File Number
EntityFileNumber
000-54163
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16192332 shares
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
21648 usd
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
21648 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17339 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19092 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
4309 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
2556 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2817101 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
2817101 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15878189 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16017851 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16189732 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16192332 shares
CY2022Q2 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2022Q3 us-gaap Bank Overdrafts
BankOverdrafts
62 usd
CY2022Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
6889 usd
CY2022Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
6889 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
38121 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
CY2022Q2 us-gaap Shares Outstanding
SharesOutstanding
shares
CY2021Q3 us-gaap Shares Outstanding
SharesOutstanding
shares
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-6265366 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5794339 usd
CY2022Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
shares
CY2022Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-139662 usd
CY2022Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
shares
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
shares
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
shares
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
Marquie Group, Inc.
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001434601
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1305 usd
CY2021Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
4161 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
99426 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
34161 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-99426 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-34161 usd
CY2022Q3 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
0 usd
CY2021Q3 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
1271434 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
40236 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
243261 usd
CY2022Q3 us-gaap Conversion Gains And Losses On Foreign Investments
ConversionGainsAndLossesOnForeignInvestments
0 usd
CY2021Q3 us-gaap Conversion Gains And Losses On Foreign Investments
ConversionGainsAndLossesOnForeignInvestments
-1453492 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
40236 usd
CY2021Q3 us-gaap Other Expenses
OtherExpenses
2968187 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-139662 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3002348 usd
CY2022Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-139662 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3002348 usd
CY2022Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16192332 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6257741 shares
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
100374 usd
CY2022Q3 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
389 usd
CY2021Q3 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
682 usd
CY2022Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 usd
CY2021Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
1453492 usd
CY2022Q3 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 usd
CY2021Q3 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
102400 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20421 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
CY2022Q3 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
36357 usd
CY2021Q3 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
40489 usd
CY2022Q3 TMGI Accrued Consulting Fees
AccruedConsultingFees
55700 usd
CY2021Q3 TMGI Accrued Consulting Fees
AccruedConsultingFees
25000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26795 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8477 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
62 usd
CY2021Q3 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
2249 usd
CY2022Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
38880 usd
CY2021Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-12500 usd
CY2021Q3 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-25272 usd
CY2022Q3 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0 usd
CY2021Q3 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
31500 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26442 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8477 usd
CY2022Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-353 usd
CY2021Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 usd
CY2022Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
353 usd
CY2021Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q3 us-gaap Interest Paid
InterestPaid
0 usd
CY2021Q3 us-gaap Interest Paid
InterestPaid
0 usd
CY2022Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q3 TMGI Initial Derivative Liability On Convertible Note Payable
InitialDerivativeLiabilityOnConvertibleNotePayable
0 usd
CY2021Q3 TMGI Initial Derivative Liability On Convertible Note Payable
InitialDerivativeLiabilityOnConvertibleNotePayable
238596 usd
CY2022Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
49608 usd
CY2022Q3 us-gaap Accounts Receivable Noncurrent Accrued Interest Writeoff
AccountsReceivableNoncurrentAccruedInterestWriteoff
0 usd
CY2021Q3 us-gaap Accounts Receivable Noncurrent Accrued Interest Writeoff
AccountsReceivableNoncurrentAccruedInterestWriteoff
25696 usd

Files In Submission

Name View Source Status
0001712543-22-000170-index-headers.html Edgar Link pending
0001712543-22-000170-index.html Edgar Link pending
0001712543-22-000170.txt Edgar Link pending
0001712543-22-000170-xbrl.zip Edgar Link pending
ex311_302ceocertification.htm Edgar Link pending
ex321_906ceocertification.htm Edgar Link pending
f10q_tmgi08312022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tmgi-20220831.xml Edgar Link completed
tmgi-20220831.xsd Edgar Link pending
tmgi-20220831_cal.xml Edgar Link unprocessable
tmgi-20220831_def.xml Edgar Link unprocessable
tmgi-20220831_lab.xml Edgar Link unprocessable
tmgi-20220831_pre.xml Edgar Link unprocessable